These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
668 related items for PubMed ID: 12239228
1. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Hoban D, Felmingham D. J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228 [Abstract] [Full Text] [Related]
2. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents. Blondeau JM, Vaughan D, Laskowski R, Borsos S, Canadian Antimicrobial Study Group. Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615 [Abstract] [Full Text] [Related]
3. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Inoue M, Lee NY, Hong SW, Lee K, Felmingham D. Int J Antimicrob Agents; 2004 Jan; 23(1):44-51. PubMed ID: 14732313 [Abstract] [Full Text] [Related]
5. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA, Ehrhardt AF, Jones RN. Am J Med; 2001 Dec 17; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [Abstract] [Full Text] [Related]
6. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998. Zhanel GG, Karlowsky JA, Low DE, Hoban DJ. J Antimicrob Chemother; 2000 May 17; 45(5):655-62. PubMed ID: 10797089 [Abstract] [Full Text] [Related]
7. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D. Braz J Infect Dis; 2003 Feb 17; 7(1):44-61. PubMed ID: 12807691 [Abstract] [Full Text] [Related]
8. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative. Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Thornsberry C, Sahm DF. Int J Antimicrob Agents; 2002 Feb 17; 19(2):119-23. PubMed ID: 11850164 [Abstract] [Full Text] [Related]
9. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y. Diagn Microbiol Infect Dis; 2012 Jun 17; 73(2):187-91. PubMed ID: 22521692 [Abstract] [Full Text] [Related]
10. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. Thornsberry C, Jones ME, Hickey ML, Mauriz Y, Kahn J, Sahm DF. J Antimicrob Chemother; 1999 Dec 17; 44(6):749-59. PubMed ID: 10590275 [Abstract] [Full Text] [Related]
11. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007. Morrissey I, Maher K, Williams L, Shackcloth J, Felmingham D, Reynolds R, BSAC Working Parties on Resistance Surveillance. J Antimicrob Chemother; 2008 Nov 17; 62 Suppl 2():ii97-103. PubMed ID: 18819984 [Abstract] [Full Text] [Related]
12. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC. Antimicrob Agents Chemother; 2006 Jun 17; 50(6):2050-7. PubMed ID: 16723565 [Abstract] [Full Text] [Related]
13. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ, CROSS Study Group. Antimicrob Agents Chemother; 2003 Jun 17; 47(6):1875-81. PubMed ID: 12760861 [Abstract] [Full Text] [Related]
14. Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program. Johnson DM, Sader HS, Fritsche TR, Biedenbach DJ, Jones RN. Diagn Microbiol Infect Dis; 2003 Sep 17; 47(1):373-6. PubMed ID: 12967753 [Abstract] [Full Text] [Related]
15. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000). Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M. Chemotherapy; 2004 Jun 17; 50(3):143-51. PubMed ID: 15272227 [Abstract] [Full Text] [Related]
16. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children. Sunakawa K, Farrell DJ. Ann Clin Microbiol Antimicrob; 2007 Aug 13; 6():7. PubMed ID: 17697316 [Abstract] [Full Text] [Related]
17. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. Zhao C, Zhang F, Wang Z, Cao B, Xu X, Sun H, Zhang R, Hu Y, Liu Z, Du Y, Chen R, Zhuo C, Su D, Liu Y, Hu B, Wang H. Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan 13; 38(1):18-22. PubMed ID: 25791651 [Abstract] [Full Text] [Related]
18. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides. Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. J Antimicrob Chemother; 2004 Aug 13; 54(2):542-5. PubMed ID: 15215227 [Abstract] [Full Text] [Related]
19. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug 13; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002). Inoue M, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, Yamaguchi K, Kohno S, Yamanaka K, Iinuma Y, Murase M, Yokoyama T, Asari S, Hirakata Y. J Infect Chemother; 2006 Feb 13; 12(1):9-21. PubMed ID: 16506084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]